Monday, June 16th, 2025

Trip.com: Set to Thrive as China’s Travel Sector Rebounds Amidst Economic Stimulus

Date of Report

October 1, 2024

Broker Name

CGS International Securities

Company Overview

Trip.com is a key player in the consumer discretionary sector, specializing in travel services and online booking in China.

Current Market Position

  • Current Market Capitalization: HK$ 40.8 billion
  • Current Price: HK$ 530.0
  • Target Price: HK$ 491.0

Analyst Recommendation

  • Recommendation: Add
  • Expected Return: The stock’s total return is anticipated to exceed 10% over the next 12 months.

Financial Projections

  • Forward P/E (2024): 17.2
  • Forward P/E (2025): 15.6

Strategic Outlook

The report highlights that Trip.com is positioned to benefit from the recent policy shifts aimed at boosting domestic travel and consumption in China. As the government encourages spending in the tourism sector, Trip.com’s comprehensive service offerings are expected to attract a growing number of consumers eager to travel.

Risks and Considerations

Investors should remain aware of potential risks, including fluctuations in travel demand and regulatory challenges. Economic conditions and consumer sentiment will play crucial roles in Trip.com’s performance.

Summary

Trip.com is presented as a strong investment opportunity within the consumer discretionary sector, benefiting from favorable government policies and a rebound in the travel market. The anticipated increase in travel demand positions Trip.com for significant growth, making it an attractive option for investors.

Longfor Group Holdings Ltd: Promising Buy Opportunity with Strong Growth Targets

Date: September 30, 2024Broker: CGS International Securities Company Overview Longfor Group Holdings Ltd is a property development company based in China. The company specializes in the development and management of residential and commercial properties....

Kalbe Farma Stock: Strong Turnaround Despite Headwinds – Maintain Buy Rating

Kalbe Farma: Solid Turnaround Despite Profit-Margin Headwinds Kalbe Farma: Solid Turnaround Despite Profit-Margin Headwinds Broker: PT Maybank Sekuritas Indonesia Date: November 3, 2024 Maintaining a BUY Rating with a Lower Target Price Kalbe Farma...

Shenzhou International (2313 HK) Stock Analysis: 2025 Growth Outlook, Target Price HK$85.60, and Margin Expansion Potential

UOB Kay Hian Date of Report: Friday, 23 May 2025 Shenzhou International Group: 2025 Outlook – Strong Order Growth, Margin Recovery, and Expansion Plans Overview: Shenzhou International Group Poised for Robust Growth in 2025...